Literature DB >> 8541253

Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder.

T E Goldberg1, E F Torrey, J M Gold, L B Bigelow, R D Ragland, E Taylor, D R Weinberger.   

Abstract

We used a paradigm involving monozygotic (MZ) twin pairs discordant for schizophrenia (n = 20) and concordant for schizophrenia (n = 8), as well as normal MZ twin pairs (n = 7) in order to study cognitive measures of genetic risk in schizophrenia. A comparison between the unaffected twins from the discordant sample and the normal twins indicated subtle attenuations in some aspects of memory and executive functioning in the unaffected group and thus provided evidence for cognitive markers of a genetic component in schizophrenia. A comparison of the affected twins from the discordant pairs and the concordant twins yielded virtually no differences, suggesting that a distinction between familial and sporadic cases is not valid in this sample. Large differences between unaffected and affected members of discordant pairs on a wide variety of variables, including IQ, attention, memory, and executive function, highlighted the magnitude of disease-specific factors.

Entities:  

Mesh:

Year:  1995        PMID: 8541253     DOI: 10.1016/0920-9964(95)00032-h

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

1.  Biological phenotypes and genetic research on schizophrenia.

Authors:  Daniel R Weinberger
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

2.  Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Authors:  A D Eastvold; R K Heaton; K S Cadenhead
Journal:  Schizophr Res       Date:  2007-04-30       Impact factor: 4.939

Review 3.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

4.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 5.  [Cognitive disorders in schizophrenic patients].

Authors:  H-P Volz; F Reischies; M Riedel
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

6.  Progress in the Prospective Study of the Schizophrenia Prodrome.

Authors:  Emery J Fu; Kristin S Cadenhead
Journal:  Curr Psychos Ther Rep       Date:  2005-12-01

7.  The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study.

Authors:  Yaling Yang; Keith H Nuechterlein; Owen Phillips; Liberty S Hamilton; Kenneth L Subotnik; Robert F Asarnow; Arthur W Toga; Katherine L Narr
Journal:  Schizophr Res       Date:  2010-11       Impact factor: 4.939

8.  Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk.

Authors:  Roberta Rasetti; Venkata S Mattay; Lisa M Wiedholz; Bhaskar S Kolachana; Ahmad R Hariri; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Am J Psychiatry       Date:  2008-12-15       Impact factor: 18.112

9.  DTNBP1 genotype influences cognitive decline in schizophrenia.

Authors:  Katherine E Burdick; Terry E Goldberg; Birgit Funke; John A Bates; Todd Lencz; Raju Kucherlapati; Anil K Malhotra
Journal:  Schizophr Res       Date:  2006-10-30       Impact factor: 4.939

Review 10.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.